BFA
CRVS icon

BlackRock Fund Advisors’s Corvus Pharmaceuticals CRVS Stock Holding History

BlackRock Fund Advisors’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.56M Buy
108,919
+16,067
+17% +$244K ﹤0.01% 3195
2016
Q3 		$1.53M Buy
92,852
+5,311
+6% +$76.6K ﹤0.01% 3195
2016
Q2 		$1.25M Buy
+87,541
New +$1.18M ﹤0.01% 3246

Other funds holding CRVS

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $443M AUM 49.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Fund Advisors's CRVS Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Corvus Pharmaceuticals (CRVS) stake by 17% in Q4 2016, buying an estimated $244K and bringing the position to 108,919 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #3195.

BlackRock Fund Advisors first reported a position in CRVS in Q2 2016 and has held it in 3 quarters since. 53 funds tracked by Wall St. Rank hold CRVS as of Q4 2016.

  • BlackRock Fund Advisors held 108,919 shares of Corvus Pharmaceuticals worth $1.56M as of Q4 2016.
  • BlackRock Fund Advisors bought 16,067 Corvus Pharmaceuticals shares in Q4 2016, an estimated $244K.
  • Corvus Pharmaceuticals made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3195 holding.
  • BlackRock Fund Advisors first reported a position in Corvus Pharmaceuticals in Q2 2016 and has held it in 3 quarters since.
  • 53 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.